跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
GENTAMICIN INJECTION USP - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
GENTAMICIN INJECTION USP
Authorized
STANDARD
GENTAMICIN INJECTION USP
hikma canada limited
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
ab83c6fb3290cf5f
Company
hikma canada limited
Type
Standard
Approval Details
Approval Id
ab83c6fb3290cf5f
Drug Approval Canada Name
GENTAMICIN INJECTION USP
Product Name
GENTAMICIN INJECTION USP
Status
Marketed
Status Date
2024-01-11
Original Market Date
2019-05-14
Din
02470462
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Intravenous , Intramuscular
Schedule
Prescription
Ahfs
08:12.02
Atc Original
J01GB03 GENTAMICIN
Atc Name
j 01 gb 03
Aig Number
0105695003
Company Name
hikma canada limited
Company Address
5995 Avebury Road, Suite 804, Mississauga, Ontario, Canada, L5R 3P9
Active Ingredients
GENTAMICIN (GENTAMICIN SULFATE)
10 MG / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
ab83c6fb3290cf5f
Type
Standard
Back to Health Canada Approvals